newsFirst-in-class oral small molecule trial data presented at 2023 ERA Congress20 June 2023 | By European Pharmaceutical ReviewAt the 2023 ERA Congress, Chinook Therapeutics revealed Phase I data for its first-in-class oral small molecule LDHA inhibitor.
newsOral antibiotics may raise risk of kidney stones14 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Paediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones...
